Maximus, Inc. Q3 2026 Earnings Recap

Shares fell 6.3% as investors reacted negatively to a cautionary outlook driven by a customer-directed pause in performance incentives on Maximus’ VA Medical Disability Exam program, which is set to weigh on fourth quarter profitability and margins.

Key Takeaways

• Q3 revenue of $1.28 billion met expectations but reflected a pullback from prior-year temporary surges in natural disaster support and clinical volumes, particularly impacting the U.S. Federal Services segment.
• Adjusted EBITDA margin improved slightly to 15.0% from 14.7% year-over-year, reflecting operational efficiencies rather than volume growth.
• U.S. Federal Services operating margin rose to 18.6% despite revenue challenges; however, a pause in incentives on the VA MDE contract will pressure margins starting Q4.
• U.S. Services revenue held steady at $418 million, with a positive growth outlook for Q4 driven by Medicaid-related state engagements.
• Operating cash flow was negative $125 million, with elevated DSO of 98 days due to administrative delays at a key federal customer, though collections have begun to improve in July.